About Kelly Blackburn
Kelly Blackburn is EVP, Clinical Development at CervoMed.
Form D filings name Kelly Blackburn as an executive officer at EIP Pharma.
Kelly Blackburn reports to the SEC as an officer of 2 public companies, including aTYR PHARMA (ATYR).
Kelly Blackburn first appears on SEC filings in 2015.
Experience
This experience comes from SEC filings. The years are when the filings name Kelly Blackburn in the role, so the role may have started earlier or lasted longer.
CI
CervoMed Inc.
EVP, Clinical Development
2023 – 2026 · Public company (CRVO)
AI
aTYR PHARMA INC
VP, Clinical Affairs
2015 – 2016 · Public company (ATYR)
Key Colleagues at Startups
The people Kelly Blackburn works with at each company, as listed on that company's latest Form D.
EIP Pharma, Inc. · Form D, Jul 20, 2023
JP
Jeff Poulton
Director
WT
William Turner
Executive officer
SG
Sylvie Gregoire
Director
FZ
Frank Zavrl
Director
JA
John Alam
CEO and director
MS
Marwan Sabbagh
Director